Abstract:
There are provided inter alia compounds of formula (I), wherein R 1 , R 2 , R 3 , R 4a and R 4b are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
Abstract:
There are provided inter alia novel N-phenyl substituted pyrrole derivativesand theiruse in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
Abstract:
There isprovided inter alianovel N-phenyl substituted pyrrole derivativesand theiruse in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
Abstract:
There are provided inter alia compounds of formula (I) wherein R 1 , R 2 , R 3 , R 4a and R 4b are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
Abstract:
There are provided inter alia compounds of formula (I), wherein R 1 , R 2 , R 3 , R 4a and R 4b are as defined in the specification and their use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.
Abstract:
There is provided inter alia a novel N-phenyl substituted pyrrole derivative and its use in therapy, especially in the treatment of bacterial (e.g. pneumococcal) infections.